Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 5:58 PM
Ignite Modification Date: 2025-12-25 @ 3:20 PM
NCT ID: NCT01856868
Description: There were 12 adverse events in six participants reported and tracked during the 8-week treatment phase of the study. Seven of the 12 events were related or possibly related to the study biopsy procedure. All adverse events were followed until resolution.
Frequency Threshold: 0
Time Frame: 8 weeks
Study: NCT01856868
Study Brief: Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Treatment With Epicatechin Purified nutritional extract (-)-epicatechin 100mg/day orally for 8 weeks. (-)-epicatechin: purified nutritional extract (-)-epicatechin 100mg/day orally for 8 weeks. 0 None 0 6 6 6 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Bruising at the biopsy site SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Non-biopsy-related flulike symptoms SYSTEMATIC_ASSESSMENT General disorders None View
Rash SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
suspected varicella (shingles) SYSTEMATIC_ASSESSMENT Immune system disorders None View
Muscle soreness SYSTEMATIC_ASSESSMENT General disorders None View
Intermittent headache SYSTEMATIC_ASSESSMENT General disorders None View